Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2001 Jan;38(1):14–19. doi: 10.1136/jmg.38.1.14

A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases

P de Lonlay 1, N Seta 1, S Barrot 1, B Chabrol 1, V Drouin 1, B Gabriel 1, H Journel 1, M Kretz 1, J Laurent 1, M Le Merrer 1, A Leroy 1, D Pedespan 1, P Sarda 1, N Villeneuve 1, J Schmitz 1, E van Schaftingen 1, G Matthijs 1, J Jaeken 1, C Korner 1, A Munnich 1, J Saudubray 1, V Cormier-Daire 1
PMCID: PMC1734729  PMID: 11134235

Abstract

INTRODUCTION—Congenital disorders of glycosylation (CDG), or carbohydrate deficient glycoprotein syndromes, form a new group of multisystem disorders characterised by defective glycoprotein biosynthesis, ascribed to various biochemical mechanisms.
METHODS—We report the clinical, biological, and molecular analysis of 26 CDG I patients, including 20 CDG Ia, two CDG Ib, one CDG Ic, and three CDG Ix, detected by western blotting and isoelectric focusing of serum transferrin.
RESULTS—Based on the clinical features, CDG Ia could be split into two subtypes: a neurological form with psychomotor retardation, strabismus, cerebellar hypoplasia, and retinitis pigmentosa (n=11), and a multivisceral form with neurological and extraneurological manifestations including liver, cardiac, renal, or gastrointestinal involvement (n=9). Interestingly, dysmorphic features, inverted nipples, cerebellar hypoplasia, and abnormal subcutaneous fat distribution were not consistently observed in CDG Ia. By contrast, the two CDG Ib patients had severe liver disease, enteropathy, and hyperinsulinaemic hypoglycaemia but no neurological involvement. Finally, the CDG Ic patient and one of the CDG Ix patients had psychomotor retardation and seizures. The other CDG Ix patients had severe proximal tubulopathy, bilateral cataract, and white matter abnormalities (one patient), or multiorgan failure and multiple birth defects (one patient).
CONCLUSIONS—Owing to the remarkable clinical variability of CDG, this novel disease probably remains largely underdiagnosed. The successful treatment of CDG Ib patients with oral mannose emphasises the paramount importance of early diagnosis of PMI deficiency.


Keywords: CDG; phosphomannomutase; phosphomannose isomerase; dolichyl-phosphate glucose:mannose 9 N-acetylglycosamine 2 glucosyltransferase

Full Text

The Full Text of this article is available as a PDF (196.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alton G., Kjaergaard S., Etchison J. R., Skovby F., Freeze H. H. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med. 1997 Apr;60(2):127–133. doi: 10.1006/bmme.1997.2574. [DOI] [PubMed] [Google Scholar]
  2. Babovic-Vuksanovic D., Patterson M. C., Schwenk W. F., O'Brien J. F., Vockley J., Freeze H. H., Mehta D. P., Michels V. V. Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. J Pediatr. 1999 Dec;135(6):775–781. doi: 10.1016/s0022-3476(99)70103-4. [DOI] [PubMed] [Google Scholar]
  3. Etchison J. R., Freeze H. H. Enzymatic assay of D-mannose in serum. Clin Chem. 1997 Mar;43(3):533–538. [PubMed] [Google Scholar]
  4. Eyskens F., Ceuterick C., Martin J. J., Janssens G., Jaeken J. Carbohydrate-deficient glycoprotein syndrome with previously unreported features. Acta Paediatr. 1994 Aug;83(8):892–896. doi: 10.1111/j.1651-2227.1994.tb13166.x. [DOI] [PubMed] [Google Scholar]
  5. Imbach T., Burda P., Kuhnert P., Wevers R. A., Aebi M., Berger E. G., Hennet T. A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6982–6987. doi: 10.1073/pnas.96.12.6982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Imbach T., Schenk B., Schollen E., Burda P., Stutz A., Grunewald S., Bailie N. M., King M. D., Jaeken J., Matthijs G. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest. 2000 Jan;105(2):233–239. doi: 10.1172/JCI8691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jaeken J., Artigas J., Barone R., Fiumara A., de Koning T. J., Poll-The B. T., de Rijk-van Andel J. F., Hoffmann G. F., Assmann B., Mayatepek E. Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins. J Inherit Metab Dis. 1997 Jul;20(3):447–449. doi: 10.1023/a:1005331523477. [DOI] [PubMed] [Google Scholar]
  8. Jaeken J., Carchon H., Stibler H. The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders? Glycobiology. 1993 Oct;3(5):423–428. doi: 10.1093/glycob/3.5.423. [DOI] [PubMed] [Google Scholar]
  9. Jaeken J., De Cock P., Stibler H., Van Geet C., Kint J., Ramaekers V., Carchon H. Carbohydrate-deficient glycoprotein syndrome type II. J Inherit Metab Dis. 1993;16(6):1041–1041. doi: 10.1007/BF00711522. [DOI] [PubMed] [Google Scholar]
  10. Jaeken J., Matthijs G., Barone R., Carchon H. Carbohydrate deficient glycoprotein (CDG) syndrome type I. J Med Genet. 1997 Jan;34(1):73–76. doi: 10.1136/jmg.34.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jaeken J., Matthijs G., Saudubray J. M., Dionisi-Vici C., Bertini E., de Lonlay P., Henri H., Carchon H., Schollen E., Van Schaftingen E. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet. 1998 Jun;62(6):1535–1539. doi: 10.1086/301873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jaeken J., Schachter H., Carchon H., De Cock P., Coddeville B., Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child. 1994 Aug;71(2):123–127. doi: 10.1136/adc.71.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kim S., Westphal V., Srikrishna G., Mehta D. P., Peterson S., Filiano J., Karnes P. S., Patterson M. C., Freeze H. H. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) J Clin Invest. 2000 Jan;105(2):191–198. doi: 10.1172/JCI7302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Körner C., Knauer R., Holzbach U., Hanefeld F., Lehle L., von Figura K. Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13200–13205. doi: 10.1073/pnas.95.22.13200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Körner C., Knauer R., Stephani U., Marquardt T., Lehle L., von Figura K. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase. EMBO J. 1999 Dec 1;18(23):6816–6822. doi: 10.1093/emboj/18.23.6816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Matthijs G., Schollen E., Pardon E., Veiga-Da-Cunha M., Jaeken J., Cassiman J. J., Van Schaftingen E. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet. 1997 May;16(1):88–92. doi: 10.1038/ng0597-88. [DOI] [PubMed] [Google Scholar]
  17. Matthijs G., Schollen E., Van Schaftingen E., Cassiman J. J., Jaeken J. Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Am J Hum Genet. 1998 Mar;62(3):542–550. doi: 10.1086/301763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mayatepek E., Schröder M., Kohlmüller D., Bieger W. P., Nützenadel W. Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I. Acta Paediatr. 1997 Oct;86(10):1138–1140. doi: 10.1111/j.1651-2227.1997.tb14825.x. [DOI] [PubMed] [Google Scholar]
  19. Niehues R., Hasilik M., Alton G., Körner C., Schiebe-Sukumar M., Koch H. G., Zimmer K. P., Wu R., Harms E., Reiter K. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest. 1998 Apr 1;101(7):1414–1420. doi: 10.1172/JCI2350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Panneerselvam K., Freeze H. H. Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. J Clin Invest. 1996 Mar 15;97(6):1478–1487. doi: 10.1172/JCI118570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Petersen M. B., Brostrøm K., Stibler H., Skovby F. Early manifestations of the carbohydrate-deficient glycoprotein syndrome. J Pediatr. 1993 Jan;122(1):66–70. doi: 10.1016/s0022-3476(05)83488-2. [DOI] [PubMed] [Google Scholar]
  22. Schachter H., Jaeken J. Carbohydrate-deficient glycoprotein syndrome type II. Biochim Biophys Acta. 1999 Oct 8;1455(2-3):179–192. doi: 10.1016/s0925-4439(99)00054-x. [DOI] [PubMed] [Google Scholar]
  23. Seta N., Barnier A., Hochedez F., Besnard M. A., Durand G. Diagnostic value of Western blotting in carbohydrate-deficient glycoprotein syndrome. Clin Chim Acta. 1996 Oct 29;254(2):131–140. doi: 10.1016/0009-8981(96)06379-6. [DOI] [PubMed] [Google Scholar]
  24. Stibler H., Holzbach U., Tengborn L., Kristiansson B. Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type I. Blood Coagul Fibrinolysis. 1996 Mar;7(2):118–126. doi: 10.1097/00001721-199603000-00003. [DOI] [PubMed] [Google Scholar]
  25. Van Schaftingen E., Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett. 1995 Dec 27;377(3):318–320. doi: 10.1016/0014-5793(95)01357-1. [DOI] [PubMed] [Google Scholar]
  26. de Koning T. J., Dorland L., van Diggelen O. P., Boonman A. M., de Jong G. J., van Noort W. L., De Schryver J., Duran M., van den Berg I. E., Gerwig G. J. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun. 1998 Apr 7;245(1):38–42. doi: 10.1006/bbrc.1998.8385. [DOI] [PubMed] [Google Scholar]
  27. de Lonlay P., Cuer M., Vuillaumier-Barrot S., Beaune G., Castelnau P., Kretz M., Durand G., Saudubray J. M., Seta N. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. J Pediatr. 1999 Sep;135(3):379–383. doi: 10.1016/s0022-3476(99)70139-3. [DOI] [PubMed] [Google Scholar]
  28. van Eijk H. G., van Noort W. L., de Jong G., Koster J. F. Human serum sialo transferrins in diseases. Clin Chim Acta. 1987 Jun 15;165(2-3):141–145. doi: 10.1016/0009-8981(87)90157-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES